Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for lung cancer: the guidelines.

Peter B Bach1, Dennis E Niewoehner, William C Black

  • 1Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021, USA. bachp@mskcc.org

Chest
|January 16, 2003
PubMed
Summary

Lung cancer screening with chest x-ray and sputum cytology has not proven effective. Early low-dose CT (LDCT) screening shows promise, but further clinical trials are needed for recommendations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Cancer discovery·2026
Same author

Chromosomal Inversions and Their Potential Impact on the Evolution of Arboviral Vector Aedes aegypti.

Genome biology and evolution·2025
Same author

Patina of precision: risk models for lung cancer screening eligibility.

BMJ oncology·2025
Same author

Cancer treatment monitoring using cell-free DNA fragmentomes.

Nature communications·2024
Same author

Quality of Treatment Selection for Medicare Beneficiaries With Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.

Journal of clinical medicine·2024

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Background:

  • Lung cancer survival rates differ significantly based on stage at diagnosis.
  • Effective screening methods are crucial for early detection and improved patient outcomes.
  • Previous screening modalities have not demonstrated a reduction in lung cancer mortality.

Framework:

  • Investigating the efficacy of various lung cancer screening modalities.
  • Evaluating the impact of screening on lung cancer mortality rates.
  • Comparing the effectiveness of chest x-ray, sputum cytology, and low-dose CT (LDCT).

Implementation:

  • Randomized controlled trials of chest x-ray and sputum cytology have yielded negative results.
  • Current data on low-dose CT (LDCT) screening is primarily from observational studies.

Related Experiment Videos

  • LDCT screening is recommended only within the framework of well-designed clinical trials.

    • Implications:

    • Chest x-ray and sputum cytology are not recommended for lung cancer screening.
    • Low-dose CT (LDCT) shows potential but requires further rigorous evaluation.
    • The findings underscore the importance of evidence-based recommendations for cancer screening programs.